Sort
64,565 grants matching “drug discovery”
Structure-based Discovery of Critical Vulnerabilities of Mycobacteria
$2,387,567James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2022 · AI
Xavier RCMI Center for Cancer Research
$2,386,547Gene D'amour · Xavier University Of Louisiana · G12 · FY2014 · MD
Interdisciplinary Center for Male Contraceptive Research and Drug Development
$2,386,376Joseph S Tash · University Of Kansas Medical Center · U54 · FY2011 · HD
Genetic Epidemiology and Multi-Omics Analyses in Familial and Sporadic Alzheimer's Disease Among Secular Caribbean Hispanics and Religious Order
$2,385,628Richard Mayeux · Columbia University Health Sciences · R01 · FY2024 · AG
Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery
$2,385,204Colleen B Jonsson · University Of Tennessee Health Sci Ctr · UC7 · FY2024 · AI
Nanometer distance assay to uncover protein dynamics
$2,385,000Gabriela Schlau-Cohen · Massachusetts Institute Of Technology · DP2 · FY2017 · GM
Discovery of next-generation dengue NS4B inhibitors
$2,384,773Christopher Sarko · University Of Texas Med Br Galveston · U19 · FY2022 · AI
Developmental Research Projects Program (DRPP)
$2,384,459Suranganie F Dharmawardhane · University Of Puerto Rico Med Sciences · P20 · FY2025 · GM
Developmental Research Projects Program (DRPP)
$2,384,459Suranganie F Dharmawardhane · University Of Puerto Rico Med Sciences · P20 · FY2022 · GM
Therapies for patients with rare tumors and genetic tumor predisposition
$2,384,333Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
UMDNJ/Rutgers University CounterACT Research Center of Excellence
$2,381,960Jeffrey D Laskin · Rbhs-Robert Wood Johnson Medical School · U54 · FY2013 · AR
Center for Systems Neurogenetics of Addiction
$2,381,552Elissa J Chesler · Jackson Laboratory · P50 · FY2017 · DA
Multi-organ human-on-a-chip system to address overdose and acute and chronic efficacy and off-target toxicity
$2,381,424James J Hickman · University Of Central Florida · UH3 · FY2021 · TR
Discovery and Analytical Validation of Inflammatory Bio-Signatures of the Human Pain Experience
$2,381,168Alan Rodney Prossin · University Of Texas Hlth Sci Ctr Houston · R61 · FY2019 · NS
Developing a NAMPT activator for Alzheimerâs disease
$2,380,457Beibei Chen · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · AG
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder
$2,380,269Lawrence R Toll · Phoenix Pharmalabs, Inc. · U01 · FY2023 · DA
Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer
$2,379,065Robert J Coffey · Vanderbilt University Medical Center · P50 · FY2020 · CA
A common denominator of pathogenesis; a rare opportunity for novel therapeutic de
$2,377,500Douglas Alan Mitchell · University Of Illinois At Urbana-Champaign · DP2 · FY2011 · OD
Rapid reverse translational drug repositioning
$2,377,500Rong Xu · Case Western Reserve University · DP2 · FY2014 · HD
Developing a NAMPT activator for Alzheimerâs disease
$2,376,637Beibei Chen · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · AG
The Psychophysiology of Fear and Anxiety
$2,376,466Christian Grillon · National Institute Of Mental Health · ZIA · FY2019 · MH
Case GI SPORE
$2,375,000Sanford D Markowitz · Case Western Reserve University · P50 · FY2017 · CA
Case GI SPORE
$2,375,000Sanford D Markowitz · Case Western Reserve University · P50 · FY2020 · CA
CSHL Molecular Target Discovery and Development Center
$2,374,043Scott Powers · Cold Spring Harbor Laboratory · RC2 · FY2010 · CA
Medicinal Chemistry and Lead Development Core
$2,372,574Joseph A Maddry · University Of Alabama At Birmingham · U19 · FY2016 · AI